Difficult to Treat Gram-Negative Bacteria—The Indian Scenario

IF 3.1 4区 医学 Q2 INFECTIOUS DISEASES
Niraj Bannore, Farhad Kapadia, Ashit Hegde
{"title":"Difficult to Treat Gram-Negative Bacteria—The Indian Scenario","authors":"Niraj Bannore, Farhad Kapadia, Ashit Hegde","doi":"10.1007/s11908-024-00834-y","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3><p>Over 50% of the infections in most ICUs in tertiary care centres in India are caused by difficult to treat (DTR) gram-negative bacteria. The options available for the treatment of these infections are quite limited. This review discusses the epidemiology of these DTR infections in India and explores the various treatment strategies for these infections which are relevant in an Indian setting.</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>The most common organisms causing DTR infections in India are <i>Klebsiella pneumoniae</i>, <i>Escherichia coli</i>, <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i>. The mechanisms of resistance in these organisms are not the same as those in DTR organisms prevalent in the western world. Treatment strategies recommended by western guidelines may not work in India. Management of these DTR organisms needs to be tailored to the situation in India.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>Overuse of antibiotics has led to an alarming rate of DTR infections in Indian ICUs. The polymyxins are often the only drugs which are effective against many of these infections. Physicians in India and the government need to take urgent measures to control the spread of these organisms.</p><h3 data-test=\"abstract-sub-heading\">Key points</h3>\n<ul>\n<li>\n<p>Antibiotic overuse has led to a situation where over 50% of infections in Indian ICUs are caused by DTR organisms.</p>\n</li>\n<li>\n<p>Carbapenemase production is the primary mechanism of resistance in carbapenem-resistant Enterobacterales (CRE). Efflux pumps, altered outer membrane porin and production of carbapenemases are all implicated in DTR <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i>.</p>\n</li>\n<li>\n<p>KPC production is very uncommon in the CRE prevalent in India. Western guidelines may therefore not be relevant in India.</p>\n</li>\n<li>\n<p>The polymyxins (in combination) and ceftazidime/avibactam with aztreonam are the drugs most often used to deal with DTR gram-negative bacteria in India.</p>\n</li>\n<li>\n<p>Local delivery of antibiotics may be indicated in the management of these DTR infections in special sites like meningitis and pneumonia.</p>\n</li>\n</ul>","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2024-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Infectious Disease Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11908-024-00834-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of Review

Over 50% of the infections in most ICUs in tertiary care centres in India are caused by difficult to treat (DTR) gram-negative bacteria. The options available for the treatment of these infections are quite limited. This review discusses the epidemiology of these DTR infections in India and explores the various treatment strategies for these infections which are relevant in an Indian setting.

Recent Findings

The most common organisms causing DTR infections in India are Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii and Pseudomonas aeruginosa. The mechanisms of resistance in these organisms are not the same as those in DTR organisms prevalent in the western world. Treatment strategies recommended by western guidelines may not work in India. Management of these DTR organisms needs to be tailored to the situation in India.

Summary

Overuse of antibiotics has led to an alarming rate of DTR infections in Indian ICUs. The polymyxins are often the only drugs which are effective against many of these infections. Physicians in India and the government need to take urgent measures to control the spread of these organisms.

Key points

  • Antibiotic overuse has led to a situation where over 50% of infections in Indian ICUs are caused by DTR organisms.

  • Carbapenemase production is the primary mechanism of resistance in carbapenem-resistant Enterobacterales (CRE). Efflux pumps, altered outer membrane porin and production of carbapenemases are all implicated in DTR Pseudomonas aeruginosa and Acinetobacter baumannii.

  • KPC production is very uncommon in the CRE prevalent in India. Western guidelines may therefore not be relevant in India.

  • The polymyxins (in combination) and ceftazidime/avibactam with aztreonam are the drugs most often used to deal with DTR gram-negative bacteria in India.

  • Local delivery of antibiotics may be indicated in the management of these DTR infections in special sites like meningitis and pneumonia.

Abstract Image

难以治疗的革兰氏阴性细菌--印度的情况
综述目的在印度三级医疗中心的大多数重症监护病房中,50% 以上的感染是由难以治疗(DTR)的革兰氏阴性菌引起的。治疗这些感染的方法非常有限。本综述讨论了这些 DTR 感染在印度的流行病学,并探讨了与印度环境相关的治疗这些感染的各种策略。这些微生物的耐药机制与西方国家流行的 DTR 微生物的耐药机制不同。西方指南推荐的治疗策略在印度可能行不通。摘要抗生素的过度使用导致印度重症监护病房中的 DTR 感染率达到了惊人的水平。多粘菌素通常是唯一对许多此类感染有效的药物。印度的医生和政府需要采取紧急措施来控制这些微生物的传播。要点抗生素的过度使用导致印度重症监护病房中超过 50% 的感染是由 DTR 微生物引起的。外排泵、外膜孔蛋白的改变和碳青霉烯酶的产生都与 DTR 铜绿假单胞菌和鲍曼不动杆菌有关。在印度,多粘菌素(联合用药)和头孢唑肟/阿维菌素加阿曲南是治疗 DTR 革兰氏阴性菌最常用的药物。在治疗脑膜炎和肺炎等特殊部位的 DTR 感染时,可在局部使用抗生素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Infectious Disease Reports
Current Infectious Disease Reports INFECTIOUS DISEASES-
CiteScore
6.70
自引率
0.00%
发文量
19
期刊介绍: This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of infectious disease. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as HIV/AIDS, sexually transmitted diseases, tropical and travel medicine, and urinary tract infections. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信